Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Sernova Corp (OP: SEOVF)
0.1800 USD  UNCHANGED
Official Closing Price  /  Updated: 10:21 AM EDT, Sep 19, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 5,000
Open 0.1800
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1800
Today's Range 0.1800 - 0.1800
52wk Range 0.1171 - 0.2080
Shares Outstanding 159,893,223
Dividend Yield N/A
Performance
YTD
+29.96%
+29.96%
1 Month
+18.34%
+18.34%
3 Month
+5.88%
+5.88%
6 Month
+53.19%
+53.19%
1 Year
+17.57%
+17.57%
Top News
More News
Sernova Renews Frontier Flex for Canadian Investor Relations and Marketing
category None
from TheNewswire.com - RSS (Media)
Sernova Completes Oversubscribed Private Placement of $4,684,564
category None
from TheNewswire.com - RSS (Media)
More News
Read More
Sernova Announces Second Closing of Private Placement
category None
from TheNewswire.com - RSS (Media)
Sernova Announces First Closing of Private Placement
category None
from TheNewswire.com - RSS (Media)
Sernova Announces Up to $3 Million Private Placement Financing
category None
from TheNewswire.com - RSS (Media)
Sernova's Phase I/II US Clinical Trial for Type-1 Diabetes Advances Following Positive Preliminary Safety and Efficacy Data
category None
from TheNewswire.com - RSS (Media)
Sernova Corp Presents Positive Preliminary Safety and Efficacy Data in its Phase I/II Clinical Trial for Type-1 Diabetes
category None
from TheNewswire.com - RSS (Media)
Sernova's Principal Investigator to Present Interim Data from the Company's Ongoing Phase I/II Cell Pouch Clinical Trial at the 17th World Congress of the International Pancreas and Islet Transplant A
category None
from TheNewswire.com - RSS (Media)
Sernova Corp Announces Appointment of Deborah Brown to its Board of Directors
category None
from TheNewswire.com - RSS (Media)
Sernova Announces Collaboration to Advance Therapeutic Cell Pouch Technologies for the Treatment of Hypothyroidism
category None
from TheNewswire.com - RSS (Media)
Sernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical Study for Diabetes
category None
from TheNewswire.com - RSS (Media)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.